WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of biopharmaceutical entrepreneur Nancy T. Chang, Ph.D. to its Board of Directors. Dr. Chang’s extensive experience in operations coupled with more than 25 years of expertise in drug development will provide enhanced strategic vision to the Charles River Laboratories Board of Directors.
